Nutrients
Cure8 research brief
Why This Matters
A preclinical mouse study found that heat-inactivated Lacticaseibacillus paracasei PC-01 reduced colitis signs and altered gut microbiota, which may be of interest for microbiome-targeted IBD research but does not show human benefit.
Who Should Pay Attention
Researchers (microbiome, probiotics/postbiotics), basic scientists using DSS models; patients and clinicians interested in early-stage microbiome research should note this is preliminary.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
The paper used a standard DSS mouse model of intestinal inflammation to test a heat-inactivated probiotic strain (PC-01). Treated mice had lower disease activity and improved histology scores, along with shifts in gut bacterial groups (increases in Barnesiella and Muribaculum; decreases in opportunistic taxa named in the abstract).
The authors conclude the heat-inactivated product modulated microbiota homeostasis and suppressed intestinal inflammatory responses. This is preclinical, not clinical: results are from mice and reported in an abstract-format extraction. It does not provide evidence that the same product is safe or effective in people with IBD.
Avoid applying these findings directly to treatment decisions.
Keep In Mind
Findings come from a DSS-induced colitis mouse model and are reported at abstract depth. Heat-inactivated bacteria (postbiotics) differ from live probiotics; effectiveness and safety in humans are not addressed here.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationNutrients
AuthorsZhao X, Yang C, Gao L +6 more
Study typeJournal article
Indexed viaEurope PMC
Source typeResearch paper
PublishedSep 28, 2026, 12:00 AM
Content availableJournal abstract
Funding disclosed by the source: Science and technology project of the Food Science and Engineering College, Inner Mongolia Agricultural University - SPKJ202206; Natural Science Foundation of Inner Mongolia Autonomous Region - 2024QN03052; National Key Research and Development Program of China - 2024YFA1307002; National Natural Science Foundation of China - 23402050
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Yakuchinone B Ameliorates DSS-Induced Colitis by Modulating the Gut Microbiota-Metabolite Axis
The paper describes a preclinical demonstration that a plant-derived compound reduced inflammation and changed gut microbiota and metabolite profiles in a mouse colitis model, suggesting a possible route for future...
Anti-inflammatory activity of Chlorella polysaccharide AHP.
The study reports that Chlorella-derived polysaccharide AHP reduced inflammation, supported barrier repair, and changed gut microbiota in cell and mouse colitis models—suggesting a potential new bioactive candidate for...
Lacticaseibacillus rhamnosus -Derived Extracellular Vesicles Alleviate Colitis via PPAR Signaling and the Gut Microbiota–Metabolite Axis
This preclinical study suggests probiotic-derived extracellular vesicles may reduce intestinal inflammation and restore barrier function via PPARγ signaling and changes to the gut microbiome—an early step toward...